Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Genomic Biomarkers Market Report 2024" has been added to ResearchAndMarkets.com's offering. The genomic biomarkers market size has grown rapidly in ...
As part of this study, the team also presented a novel prognostic biomarker for osteosarcoma: loss of heterozygosity (LOH). LOH occurs when one copy of a genomic region is lost. In osteosarcoma ...
Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma. Expanded biomarker analysis of an ...
Development of focused research programs to identify human genomic ADR susceptibility biomarkers for specific drugs or drug classes that have significant public health impact. Development of a ...